It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...

Researchers at The Tisch Cancer Institute at Mount Sinai have uncovered a major reason why some colorectal cancers (CRC) ...

Understanding the mechanisms of resistance to cancer treatments is necessary to find effective therapies at different stages of the disease. Scientists at UT Southwestern Medical Center studied the ...

They describe the strength of evidence as compelling, highlighting the therapeutic potential of maintaining CDK4/6 inhibitor treatment when combating drug-resistant breast cancer. They also highlight ...

Here, we demonstrate that sustained CDK4/6i therapy, either alone or combined with CDK2i, significantly suppresses the growth of drug-resistant HR + breast cancer. Continued CDK4/6i treatment induces ...

Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks larger ones without side effects. Named ErSo-TFPy, this drug shows ...

Although these drugs are better tolerated than chemotherapy, they still have side effects that diminish quality of life and can leave people at risk for cancer recurrence and treatment resistance.

Although these drugs are better tolerated than chemotherapy, they still have side effects that diminish quality of life and can leave people at risk for cancer recurrence and treatment resistance.

Dr Andriy Strokan says his hospital in Kyiv treats many patients with drug-resistant infections The nature of this war also means patients are exposed to far more strains of infection than they ...

The NICE decision was supported by data from the Phase III ADAURA trial (NCT05120349), which demonstrated that post-surgical treatment with Tagrisso reduced ... which tested the combination of its ...

Corresponding Author: Leif W. Ellisen, MGH Cancer Center, CPZN-4204, 185 Cambridge Street, Boston, MA 02114. E-mail: [email protected] Clin Cancer Res 2025;XX:XX–XX R.O. Abelman, B. Wu, and H. Barnes ...

21 (UPI) --The Food and Drug Administration has approved the ... to be used together with an oral antidepressant for both treatment-resistant depression and for people with MDD.